JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on September 15, 2003; DOI: 10.1124/jpet.103.056556


0022-3565/03/3072-443-449$20.00
JPET 307:443-449, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.056556v1
307/2/443    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Han, X.
Right arrow Articles by Delude, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Han, X.
Right arrow Articles by Delude, R. L.

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

NAD+ Ameliorates Inflammation-Induced Epithelial Barrier Dysfunction in Cultured Enterocytes and Mouse Ileal Mucosa

Xiaonan Han, Takashi Uchiyama, Penny L. Sappington, Arino Yaguchi, Runkuan Yang, Mitchell P. Fink, and Russell L. Delude

Departments of Critical Care Medicine (X.H., T.U., P.L.S., A.Y., M.P.F., R.L.D.), Pathology (R.L.D.), and Surgery (M.P.F.), School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania

In the course of other experiments, we serendipitously observed that extracellular nicotinamide adenine dinucleotide (NAD+) ameliorated the development of epithelial hyperpermeability when monolayers of Caco-2 enterocyte-like cells were incubated with cytomix, a mixture containing interferon-{gamma}, interleukin-1{beta}, and tumor necrosis factor-{alpha}. We sought to characterize the effects of NAD+ on inflammation-induced epithelial barrier dysfunction using Caco-2 monolayers that were exposed to cytomix in the absence or presence of NAD+ or other purine-containing molecules. Paracellular barrier function measured as the apical-to-basolateral passage of fluorescein isothiocyanate-conjugated dextran (mol. wt. ~4000) was preserved in a concentration-dependent manner when immunostimulated Caco-2 cells were exposed to extracellular NAD+. Incubation with NAD+ prevented cytomix-induced derangements in the expression and localization of the tight junction proteins occludin and zonula occludens-1 in Caco-2 cells. Treatment of cytomix-stimulated cells with NAD+ also blocked nuclear factor-{kappa}B (NF-{kappa}B) activation, inducible nitric-oxide synthase induction, and increased production of nitric oxide (NO·). Ileal mucosal permeability to fluorescein isothiocyanate-dextran mol. wt. ~4000 was increased in mice 18 h after lipopolysaccharide (endotoxin) injection, but treatment of endotoxemic mice with NAD+ ameliorated the development of gut mucosal hyperpermeability. Thus, extracellular NAD+ seems to ameliorate inflammation-induced intestinal epithelial barrier dysfunction by inhibiting NF-{kappa}B activation and increased NO· production.


Received for publication July 3, 2003
Accepted August 7, 2003.

Address correspondence to: Dr. Russell L. Delude, 615 Scaife Hall, 3550 Terrace St., Pittsburgh, PA 15261. E-mail: deluder{at}ccm.upmc.edu




This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. A. Clark, H. Gan, A. J. Samocha, A. C. Fox, T. G. Buchman, and C. M. Coopersmith
Enterocyte-specific epidermal growth factor prevents barrier dysfunction and improves mortality in murine peritonitis
Am J Physiol Gastrointest Liver Physiol, September 1, 2009; 297(3): G471 - G479.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
X Han, X Ren, I Jurickova, K Groschwitz, B A Pasternak, H Xu, T A Wilson, S P Hogan, and L A Denson
Regulation of intestinal barrier function by signal transducer and activator of transcription 5b
Gut, January 1, 2009; 58(1): 49 - 58.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
T. Luk, Z. Malam, and J. C. Marshall
Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity
J. Leukoc. Biol., April 1, 2008; 83(4): 804 - 816.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.